- Report
- March 2021
- 31 Pages
Global
From €3841EUR$3,995USD£3,295GBP
- Clinical Trials
- March 2020
- 1096 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- April 2018
Global
From €962EUR$1,000USD£825GBP
- Drug Pipelines
- October 2020
- 1308 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Drug Pipelines
- October 2020
- 59 Pages
Global
From €3365EUR$3,500USD£2,887GBP
- Drug Pipelines
- June 2020
- 92 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Clinical Trials
- January 2020
- 500 Pages
Global
From €2308EUR$2,400USD£1,980GBP
- Report
- March 2019
- 110 Pages
Global
From €3125EUR$3,250USD£2,681GBP
- Report
- June 2018
- 15 Pages
Global
From €9615EUR$10,000USD£8,249GBP
- Report
- July 2021
- 117 Pages
Global
From €3200EUR$3,565USD£2,841GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- November 2022
- 159 Pages
Global
From €3365EUR$3,500USD£2,887GBP
- Report
- September 2022
- 1079 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- July 2022
- 51 Pages
Global
From €3365EUR$3,500USD£2,887GBP
- Drug Pipelines
- March 2019
- 44 Pages
Global
From €3365EUR$3,500USD£2,887GBP
- Report
- December 2022
- 42 Pages
Global
From €3365EUR$3,500USD£2,887GBP
- Report
- July 2023
- 132 Pages
Global
From €913EUR$950USD£784GBP
- Report
- July 2023
- 132 Pages
Global
From €913EUR$950USD£784GBP
- Report
- September 2022
- 251 Pages
Global
From €5510EUR$5,730USD£4,727GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more